enVVeno Medical Corporation
NVNO
$10.40
$0.404.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.02% | 17.69% | 32.19% | -48.66% | 27.71% |
| Total Depreciation and Amortization | 5.98% | -2.50% | -7.69% | 6.56% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.21% | -1.51% | -52.27% | 80.24% | -25.62% |
| Change in Net Operating Assets | 95.00% | 22.86% | -152.79% | 375.10% | -259.70% |
| Cash from Operations | 5.95% | 21.61% | -18.22% | 7.54% | 21.29% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.76% | 14.54% | 29.15% | -45.65% | 147.06% |
| Cash from Investing | -33.76% | 14.54% | 29.38% | -45.74% | 147.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 224.48% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 224.48% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.77% | 404.20% | 44.01% | -175.49% | 107.32% |